Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Dec. 30, 1997

S-22068: effects on glucose tolerance and plasma insulin in mice

Dec. 30, 1997

Boehringer Mannheim presents new calcium regulators

Dec. 30, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

Otsuka's new antidiabetic agents

Dec. 29, 1997

Neurogen updates its NPY program for obesity

Dec. 24, 1997

Biorex and Abbott sign definitive agreement for bimoclomol

Dec. 23, 1997

Forbes files IND to begin phase II trials of Cardiorex in primary hypercholesterolemia

Dec. 23, 1997

GH secretagogues under development at Merck

Dec. 23, 1997

Lilly research leads to the discovery of new antiobesity compounds

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...